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Adipokine Resistin Is a Key Player
to Modulate Monocytes, Endothelial Cells,
and Smooth Muscle Cells, Leading to Progression
of Atherosclerosis in Rabbit Carotid Artery
Youngjin Cho, MD,* Sang-Eun Lee, MD,* Hyun-Chae Lee, MS,† Jin Hur, PHD,† Sahmin Lee, MD,*
Seock-Won Youn, MS,† Jaewon Lee, BA,† Ho-Jae Lee, BA,† Tae-Kyu Lee, BA,†
Jonghanne Park, MD,† Seok-Jae Hwang, MD,* Yoo-Wook Kwon, PHD,† Hyun-Jai Cho, MD,*†
Byung-Hee Oh, MD,* Young-Bae Park, MD,* Hyo-Soo Kim, MD*†
Seoul, Korea
Objectives We investigated the effects of human resistin on atherosclerotic progression and clarified its underlying mecha-
nisms.
Background Resistin is an adipokine first identified as a mediator of insulin resistance in murine obesity models. But, its role
in human pathology is under debate. Although a few recent studies suggested the relationship between resistin
and atherosclerosis in humans, the causal relationship and underlying mechanism have not been clarified.
Methods We cloned rabbit resistin, which showed 78% identity to human resistin at the complementary deoxyribonucleic
acid level, and its expression was examined in 3 different atherosclerotic rabbit models. To evaluate direct role
of resistin on atherosclerosis, collared rabbit carotid arteries were used. Histological and cell biologic analyses
were performed.
Results Rabbit resistin was expressed by macrophages of the plaque in the 3 different atherosclerotic models. Peri-
adventitial resistin gene transfer induced macrophage infiltration and expression of various inflammatory cyto-
kines, resulting in the acceleration of plaque growth and destabilization. In vitro experiments elucidated that
resistin increased monocyte-endothelial cell adhesion by upregulating very late antigen-4 on monocytes and
their counterpart vascular cell adhesion molecule-1 on endothelial cells. Resistin augmented monocyte infiltra-
tion in collagen by direct chemoattractive effect as well as by enhancing migration toward monocyte chemotac-
tic protein-1. Administration of connecting segment-1 peptide, which blocks very late antigen-4  vascular cell
adhesion molecule-1 interaction, ameliorated neointimal growth induced by resistin in vivo.
Conclusions Our results indicate that resistin aggravates atherosclerosis by stimulating monocytes, endothelial cells, and vas-
cular smooth muscle cells to induce vascular inflammation. These findings provide the first insight on the causal
relationship between resistin and atherosclerosis. (J Am Coll Cardiol 2011;57:99–109) © 2011 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.07.035r
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tbesity is a well-known principal risk factor for metabolic
isorders and cardiovascular diseases, and recent studies
ave shown that numbers of bioactive molecules secreted
rom adipose tissue contribute this connection (1–3). Resis-
in is 1 of these adipocyte-derived molecules, which was first
dentified as a pivotal hormone linking obesity and insulin
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ersies on its role in human pathology, showing variable
ssociations with insulin resistance (5,6). Interestingly, re-
istin in humans is known to be expressed in atherosclerotic
laque (7), and its plasma levels are associated with coronary
eart disease (8) and future cardiovascular death (9). Several
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Effects of Resistin on Atherosclerosis Progression December 28, 2010/January 4, 2011:99–109in vitro studies demonstrated
that resistin upregulates expres-
sion of inflammatory cytokines
and adhesion molecules in hu-
man endothelial cells (10), in-
creases smooth muscle cell pro-
liferation (11) and migration (7),
and accelerates foam cell forma-
tion (12). Despite these early
studies, however, its role in ath-
erosclerosis is now only emerg-
ing, and it has not been identi-
fied whether resistin expression is
just a simple feature of athero-
sclerotic progression or directly
participates in the process.
Therefore we investigated the
pathologic role of human resistin
in atherosclerotic plaque progres-
sion and performed mechanistic
analysis of the causal relationship
between them.
ethods
loning of rabbit resistin. Another animal model was re-
uired for this study, because of low homology and different
xpression patterns between murine and human resistin (13–15).
e looked for resistin in rabbit and cloned it for the first
ime from messenger ribonucleic acid of rabbit bone marrow
ells, with reverse-transcriptase polymerase chain reaction.
he primers were designed from highly conserved regions
f human (GeneBank accession number AF205952), pig
AY488504), and cattle resistin (AB117718) comple-
entary deoxyribonucleic acid sequences (forward primer,
=-CACCTGCAGGATGAAGGCTCT-3=; reverse
rimer, 5=-GCTCAGGCGTTAGTCCTGATGCG-3=).
urther information is described in the Online Appendix. The
btained open reading frame of rabbit resistin was 339 base
air (bp) long (translated into 112 amino-acids), and the
ucleotide sequence was submitted to the GeneBank database
ith accession number FJ424872. Rabbit resistin was mainly
xpressed in mononuclear cells from peripheral blood and bone
arrow, just like human resistin (Online Fig. 1).
ollar placement and gene delivery. Bilateral rabbit ca-
otid arteries were exposed surgically under anesthesia, and
biologically inert silicone collars (total length 20 mm, bore
iameter 1.8 mm; generous gifts from Dr. Martin, British
eart Foundation Laboratories at University College Lon-
on) were implanted (1 around the left and 1 around the
ight carotid artery). After 1 week, the collared arteries were
e-exposed. Adenovirus expressing human resistin and
reen-fluorescence protein (Ad.Resistin/GFP) (100 l,
.5  109 pfu) was injected within the collar around the left
r right carotid artery, at random, whereas adenovirus
Abbreviations
and Acronyms
Ad.GFP  adenovirus
expressing green-
fluorescence protein
Ad.Resistin/GFP 
adenovirus expressing
human resistin and green-
fluorescence protein
CS1  connecting
segment-1
EC  endothelial cell
IL  interleukin
MCP  monocyte
chemotactic protein
TNF  tumor necrosis
factor
VCAM  vascular cell
adhesion molecule
VLA  very late antigen
VSMC  vascular smooth
muscle cellxpressing green-fluorescence protein (Ad.GFP) (100 l, f.5  109 pfu) was injected within the contra-lateral collar.
hen, rabbits were killed at Day 2 (n  2), Day 7 (n  3),
nd Day 28 (n  7) from gene delivery.
tatistical analysis. All data are presented as mean SEM.
omparisons between groups were performed by Student t
est. Because experimental and control value were obtained as
pair from each rabbit (Ad.Resistin/GFP- vs. Ad.GFP-
ransfected carotid artery or monocyte- vs. control phosphate-
uffered saline–delivered carotid artery), paired t test was used
o compare results of in vivo experiments. The SPSS version
1.0 (SPSS, Chicago, Illinois) was used for analysis, and p 
.05 was considered statistically significant.
Other methods are described in detail in the Online
ppendix.
esults
esistin expression in rabbit atherosclerosis models.
fter cloning of rabbit resistin as described previously,
xpression of resistin was explored in 3 established models
f atherosclerosis in aorta or carotid artery of cholesterol-fed
abbit: 1) without any vascular injury (Figs. 1A to 1C);
) with balloon injury (Figs. 1D to 1F); and 3) with
eri-vascular collar application (Figs. 1G to 1I). Resistin
as expressed in atherosclerotic plaque of all these 3 models
ut not in normal vessels (data not shown). Serial section
mmunohistochemistry and immunofluorescence double-
taining for resistin and RAM-11 (a rabbit macrophage
arker) showed that resistin was expressed by macrophages
n atherosclerotic plaque (Fig. 1), which was consistent with
he previous report on human resistin (7).
therosclerotic plaque growth by resistin in vivo. Given
he high homology and similar tissue expression pattern
etween rabbit and human resistin, we regarded rabbits as
dequate animals for our research. Thus, we delivered
d.Resistin/GFP or Ad.GFP solution to the peri-
dventitial space of the collared rabbit carotid arteries to
emonstrate the effects of resistin on atherosclerotic pro-
ression. The GFP expression and immunofluorescence
taining for resistin examined on Day 2 ascertained stable
ransduction of adenoviral vector to the arteries (Online
igs. 2A to 2D). Reverse-transcriptase polymerase chain
eaction result showing human resistin expression only in
he Ad.Resistin/GFP group also supported stable expres-
ion of the genes (Online Fig. 2E). Then we measured
ntima/media area ratio 4 weeks after gene delivery and
ound that atherosclerotic plaque growth was significantly
romoted by resistin (Fig. 2).
acrophage infiltration and plaque instability by resistin
n vivo. Further evaluation of plaque characteristics re-
ealed more complicated effects of resistin on atherosclerotic
rogression. Immunohistochemistry for RAM-11 revealed
hat resistin significantly increased macrophage infiltration
oth in intima and adventitia and was co-localized with
esistin expression (Online Fig. 3). Even after adjustment
or the area of neointima or adventitia, the number of
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December 28, 2010/January 4, 2011:99–109 Effects of Resistin on Atherosclerosis Progressionnfiltrated macrophages was still higher in the Ad.Resistin/
FP group than in the control group (Fig. 3A) (Table 1).
n addition, the proportion of vascular smooth muscle cell
VSMC) area—identified by -smooth muscle actin immu-
ohistochemistry staining—was significantly reduced, and
ipid accumulation tended to be greater in the Ad.Resistin/
FP group (Figs. 3B and 3C). When calculating plaque
tability score by the formula: plaque stabilization score 
-smooth muscle actin area %  collagen area %)/
macrophage area %  lipid vacuole area %) (16), it was
ecreased profoundly by resistin (Fig. 3C). These data
uggest that human resistin stimulates atherosclerotic pro-
ression in the aspects of plaque stability as well as its size.
ellular mechanisms of atherosclerosis aggravation by
esistin. Among the pivotal molecules in pathogenesis of
therosclerosis (17), resistin increased expression of inflam-
atory cytokines (interleukin [IL]-1, IL-6, tumor necrosis
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Figure 1 Expression of Resistin in the Plaques of 3 Different R
(A to C) Plaque in aorta of cholesterol-fed rabbit without any vascular injury. Immu
their colocalization (C, merged). (D to F) Plaque in balloon-injured carotid artery o
peri-vascular collar application. Serial section immunohistochemistry (D, E, G, H) a
that resistin was expressed by macrophages in atherosclerotic plaque. The upperactor [TNF]-) and vascular cell adhesion molecule mVCAM-1) in carotid arteries but not monocyte chemotac-
ic protein (MCP)-1 (Online Fig. 4). This result suggested
hat resistin might promote atherosclerotic progression by
timulating monocyte infiltration and vascular inflamma-
ion. Therefore, further in vitro experiments were per-
ormed to clarify the potential underlying mechanisms; and
he effects of resistin on 3 important cellular components of
essel wall—monocytes/macrophages, endothelial cells
ECs), and VSMCs—were explored.
First, resistin stimulated monocyte-EC adhesion by
ugmenting VLA-4 (4- and 1-integrin) expression on
onocytes (Fig. 4A, Online Fig. 5) and VCAM-1
counterpart of VLA-4) expression on ECs (Fig. 4B,
nline Fig. 6). This was supported by the blocking
xperiments with VLA-4 and VCAM-1 neutralizing
ntibodies (Figs. 4C and 4D). Second, resistin incited
onocyte infiltration and survival. Resistin increased
Ram-11 C
Ram-11
Ram-11 I
Resistin/Ram-11/DAPI
Resistin/Ram-11/DAPI
Resistin/Ram-11/DAPI
F
Models for Atherosclerosis
rescence double-staining for resistin (A, red) and RAM-11 (B, green) showed
sterol-fed rabbit. (G to I) Plaque in carotid artery of cholesterol-fed rabbit with
munofluorescence double-staining (F, I) for resistin and RAM-11 demonstrated
indicates luminal side. Arrowhead  internal elastic lamina; Bar  100 m.abbit
nofluo
f chole
nd im
regiononocyte infiltration in collagen gel not only by direct
c
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Effects of Resistin on Atherosclerosis Progression December 28, 2010/January 4, 2011:99–109hemoattractive effects on monocytes (Fig. 5A) but also
y increasing their mobility toward MCP-1 (Fig. 5B).
he WST-1 (Water-Soluble Tetrazolium Salt-1) test
evealed that resistin also increased the number of viable
onocytes in vitro (Fig. 5C). Third, resistin activated
SMCs to express VCAM-1 (Online Fig. 7).
Finally, to confirm these cellular mechanisms of resistin-
nduced atherosclerosis, soluble connecting segment (CS)-1
eptides—a VLA-4 binding motif of fibronectin—were
dministered subcutaneously to block VLA-4  VCAM-1
n vivo interaction (18,19). And in CS1 peptide-treated
abbits, resistin neither aggravated atherosclerotic plaque
rogression nor recruited more macrophages into collared
arotid arteries (Fig. 6).
ole of adventitial macrophages in neointimal growth.
rom the result that adventitial resistin gene delivery
ncreased macrophage infiltration not only in adventitia
ut also in intima (Fig. 3A, Online Fig. 3), we designed
dditional in vivo experiments. First, to determine the
ffect of peri-adventitial macrophages on plaque progres-
ion, we directly delivered rabbit monocytes to adventitia
f collared arteries. Second, to elucidate the routes of
acrophages infiltrated to neointima, we introduced 2
ifferently colored monocytes through 2 different routes;
ed-seminaphthorhodafluor stained monocytes were de-
ivered directly to adventitia of collared arteries, whereas
reen-carbocyfluorescein succinimidyl ester (CFSE)
tained monocytes were introduced intravenously. After
4 days, monocytes delivered to adventitia evidently
ccelerated neointimal growth (Figs. 7A and 7B), but
nly green-CFSE monocytes administrated intravenously
ere detected in neointima (Fig. 7C). These findings
uggest that adventitial macrophages might aggravate
A B
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Figure 2 Atherosclerotic Plaque Growth by Adventitial Transfer
(A, B) Representative hematoxylin and eosin staining images of intimal thickening
(Ad.Resistin/GFP)-transfected arteries (A) and adenovirus expressing green-fluores
of Ad.GFP or Ad.Resistin/GFP-transfected arteries (n  7, *p  0.029); arrowhealaque progression by recruiting circulating monocytes snto neointima remotely but not by infiltrating to the
laque by themselves.
iscussion
he convergence of insulin resistance and inflammation
n the pathogenesis of atherosclerotic cardiovascular dis-
ase had been recognized over the past decade (20 –22).
esistin has emerged as a new molecule to stand at the
odal point of signaling pathways to link metabolic
isorders and inflammation (23). Thus we hypothesized
hat human resistin, as an inflammatory mediator, might
e a causal factor of atherosclerosis, and here we report
hat human resistin can directly aggravate atherosclerotic
laque progression in both size and stability. Resistin
ncreased macrophage infiltration in intima and adventi-
ia of the collared carotid arteries and amplified various
nflammatory cytokine expressions in arterial walls. The
n vitro studies revealed that resistin affects not only
onocytes themselves but also their vascular counter
arts, ECs and VSMCs, thereby increasing infiltration
nd retention of monocytes in the vessel walls. The
ubsequent in vivo experiment, in which soluble CS1
eptide reversed atherosclerotic plaque progression in-
uced by resistin, also supported the results from the in
itro experiments. Furthermore, we demonstrated for the
rst time that the peri-adventitial macrophages can
ecruit circulating monocytes into neointima and aggra-
ate atherosclerosis.
ppropriateness of rabbit model for studying human
esistin. A few previous studies tested the role of resistin
n various diseases with murine models. Murine resistin,
owever, is different from that of human in amino-acid
C
/GFP
*
esistin Gene
novirus expressing human resistin and green-fluorescence protein
protein (Ad.GFP)-transfected arteries (B). (C) Intima/media (I/M) area ratio
ternal elastic lamina; arrow  external elastic lamina; bar  200 m.istin
of R
in ade
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d  inequence (13), expression patterns (14), and functions,
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December 28, 2010/January 4, 2011:99–109 Effects of Resistin on Atherosclerosis Progressionaising controversies on the implication of resistin in
uman diseases (15). This discrepancy led us to suspect that
he mouse atherosclerosis model, such as apolipoprotein-E
nockout mouse, is not suitable for investigation of human
esistin in atherosclerosis and to seek for more suitable
nimal models. Rabbit was 1 of the best candidates for our
tudy, because it has established experimental models mim-
cking human atherosclerosis (24) and is easy to manipulate.
hus, we cloned rabbit resistin and revealed that it has high
Figure 3 Macrophage Infiltration and Plaque Instability by Resi
(A) The density of macrophages was greater in Ad.Resistin/GFP group in neointim
Ram-11, Masson’s trichrome, immunohistochemistry for -smooth muscle actin (S
ferred carotid artery (B) and the proportion of collagen, lipid vacuole, and -SMA a
stability score decreased with Ad.resistin/GFP virus delivery (C, D; n  5, *p  0.omology to that of human (78% and 69% identity at romplementary deoxyribonucleic acid and amino-acid level,
espectively), especially at the globular head region (85%
mino acid sequence homology) known as the functional
omain (25). Rabbit resistin was indeed more similar than
ouse resistin to resistin of bigger animals such as pigs or
attle (Table 2). Furthermore, rabbit resistin showed tissue
xpression pattern comparable to that of human and was
xpressed by infiltrating macrophages in the atherosclerotic
laque, as shown in the previous report about human
n Vivo
adventitia (n  7, *p  0.05). (B, C) Representative immunohistochemistry for
nd hematoxylin and eosin staining images of Ad.Resistin/GFP or Ad.GFP trans-
neointima (C). Arrowhead  internal elastic lamina; bar  200 m. (D) Plaque
bbreviations as in Figure 2.stin I
a and
MA) a
rea in
05). Aesistin (7). Finally, the results showing that rabbit mono-
(Ad.Resistin/GFP)-infected compared with adenovirus expressing green-fluorescence protein (Ad.GFP)-infected artery. †Number of RAM-11 positive
cells/square millimeter in immunohistochemistry staining.
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Effects of Resistin on Atherosclerosis Progression December 28, 2010/January 4, 2011:99–109Figure 4 VLA-4 and VCAM-1 in Monocyte-EC Adhesion Mediated by Resistin
(A) Representative figures and densitometry of reverse-transcriptase polymerase chain reaction for integrins show that very late antigen-4 (VLA-4) (4-, 1-integrin)
expression in human acute monocytic leukemia cell line cells (THP-1) was increased by resistin (n  3, *p  0.011, †p  0.051). (B) Representative figures of West-
ern blot analysis demonstrate that intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1) expression in human umbilical vein endothe-
lial cell (HUVEC) was stimulated by resistin in a dose-dependent manner. (C) The THP-1 cells treated with resistin showed enhanced adhesion activity toward HUVEC
monolayer, and it was reversed by blocking antibodies against 4 or 1 integrin (n  9, ‡p  0.001). (D) Incubation of HUVECs with resistin enhanced its adhesion to
THP-1s, which was reversed by blocking VCAM-1 with its neutralizing antibodies (n  6, ‡p  0.001). mRNA  messenger ribonucleic acid.Effect of Resistin Transgene on Lesion Formation in Collared Rabbit Carotid ArteriesTable 1 Effect of Resistin Transgene on Lesion Formation in Collared Rabbit Carotid Arteries
Ad.GFP
(n  7)
Ad.Resistin
(n  7)
RI of
Ad.Resistin* p Value
Atheroma (mm2) 1.16 0.21 2.85 0.69 2.51 0.31 0.025
Intima/media area ratio 0.62 0.10 1.46 0.35 2.43 0.36 0.029
Macrophage/mm2†
Neointima 163 24 274 49 1.72 0.17 0.010
Adventitia 95 15 187 21 2.24 0.38 0.001
Resistin-positive cells/mm2
Neointima 173 33 313 36 1.98 0.20 0.001
Adventitia 72 14 150 25 2.18 0.13 0.001
Data are expressed as mean  SEM. *Relative increment (RI) in adenovirus expressing human resistin and green-fluorescence protein
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December 28, 2010/January 4, 2011:99–109 Effects of Resistin on Atherosclerosis Progressionytes responded to human resistin to express inflammatory
ytokines such as IL-1, IL-6, and TNF- (Online Fig. 8),
hich was also consistent with the previous report on
uman cells (26), implied that we could directly use
uman resistin in rabbit models to identify its role in
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Figure 5 Effects of Resistin on
Infiltration and Survival of Monocytes
(A) Vertical collagen gel invasion assay showed that human acute monocytic
leukemia cell line cells (THP-1) cells significantly infiltrated toward resistin more
than control by the virtue of direct chemotactic effect (n  3, *p  0.006).
(B) Resistin treatment on THP-1s also enhanced invasion toward monocyte
chemotactic protein-1 (MCP-1) (n  3, †p  0.003). Bar  500 m. (C) The
THP-1 cell number measured by the WST-1 (Water-Soluble Tetrazolium Salt-1)
test was increased by resistin (n  5, ‡p  0.001).therosclerosis. mroatherogenic action of resistin. As reviewed in the
ntroduction, despite reports that resistin activates ECs
nd VSMCs in vitro (7,10 –11), there has been no direct
vidence to support an active proatherogenic action of
esistin in vivo. In our study, we observed tangible and
ignificant effects of resistin on atherosclerosis. It in-
reased atherosclerotic lesion area approximately 2.5-fold
nd intima/media area ratio approximately 2.4-fold. Re-
istin also raised macrophage accumulation in intima and
dventitia by 1.7- and 2.2-fold, respectively, and aug-
ented expression of inflammatory cytokines such as
L-1, IL-6, and TNF- as well as adhesion molecule
CAM-1. Furthermore, the proportion of VSMC area
n the plaque was decreased by resistin, and plaque
tability was also reduced. However, resistin made no
ignificant difference in the number of vasa vasorum in
dventitia of our model (data not shown), although there
ave been a few reports suggesting that resistin can
ncrease angiogenesis in vitro (27). These results propose
hat resistin, by stimulating vascular inflammation and
acrophage accumulation in vessel wall, promotes ath-
rosclerotic plaque formation and destabilization.
echanism of resistin inducing vascular inflammation
nd atherosclerosis. Our in vitro studies revealed addi-
ional evidence on how resistin increased macrophage
nfiltration that resulted in atherosclerotic progression.
irst, resistin augmented monocyte-EC adhesion both by
aising expression of VLA-4 on monocytes and their
ounterpart VCAM-1 on ECs. Expression of another
mportant adhesion molecule, intercellular adhesion
olecule-1, was also increased on ECs by resistin (Fig. 5B),
ut expression of its counterpart, 2-integrin, was not
hanged by resistin (Fig. 5A). This would be the reason
hy intercellular adhesion molecule-1 neutralizing anti-
odies were less potent than VCAM-1 neutralizing
ntibodies at blocking resistin-induced adhesion of
onocytes on ECs. Second, resistin showed direct che-
oattractive effect on human acute monocytic leukemia
ell lines and their enhanced migration toward MCP-1
Fig. 5). This result, with the observations that resistin
id not upregulate the expression of MCP-1 in vivo
Online Fig. 4) or in vitro in VSMCs or fibroblasts (data
ot shown), explains the mechanism of increased macro-
hage infiltration by overexpression of resistin. More-
ver, the WST-1 study suggested that resistin can in-
rease macrophage accumulation in vessel walls by
nhancing monocyte survival. Lastly, we have shown that
esistin activates VCAM-1 expression on VSMCs, which
s known to stimulate monocyte infiltration and retention
n the plaque (28). Together these results imply that
esistin consistently affects monocytes, ECs, and VSMCs
o stimulate monocyte infiltration and retention in vessel
alls, thereby augmenting vascular inflammation and
laque development. And considering the results from
he previous studies indicating that resistin activates
onocytes to express inflammatory cytokines such as
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Effects of Resistin on Atherosclerosis Progression December 28, 2010/January 4, 2011:99–109L-6 and TNF- (26) and transforms macrophages to
oam cells (12), it is possible that monocytes infiltrated to
therosclerotic plaque can be further stimulated by resis-
in to express inflammatory cytokines and to become
oam cells, which results in further progression of
therosclerosis.
oluble CS1 as a new therapeutic treatment for athero-
clerosis. Our in vitro results showed that induction of
therosclerotic plaque by resistin was largely ascribed to
nteractions between VLA-4 of monocytes and VCAM-1
f ECs/VSMCs. To verify these in vitro findings in vivo,
Scrambled CS-1
Ad.GFP Ad.Resistin/GFP
B
A
C
Intima
*
p=0.031
Figure 6 CS1 Peptide Blocked the Effects of Resistin on Plaqu
(A) I/M area ratio of Ad.GFP or Ad.Resistin/GFP-transfected arteries in connecting
area ratio between Ad.GFP and Ad.Resistin/GFP-transfected arteries shown in scra
tative hematoxylin and eosin staining images of intimal thickening in scramble pep
Arrowhead  internal elastic lamina; arrow  external elastic lamina; bar  200
not differ between Ad.Resistin/GFP- and Ad.GFP-transfected arteries; *p  0.05. Ae employed a competitive inhibitor of VLA-4 – oCAM-1 binding, soluble CS1 peptide (19). As a result,
dministration of CS1 peptides almost completely sup-
ressed aggravating effects of resistin on atherosclerotic
laque— both in size and number of infiltrated macro-
hages (Fig. 6)— emphasizing the importance of VLA-
–VCAM-1 interaction in resistin-induced atherosclero-
is. By contrast, the VLA-4 –VCAM-1 pathway is not
pecific to resistin, and administration of CS1 peptides
educed the size of atherosclerotic plaque even in control
FP-transfected arteries. However, the result that resis-
in, compared with control, made no difference in the size
CS-1
Ad.GFP Ad.Resistin/GFP
Adventitia
*
p=0.608
gression
ent-1 (CS1) or its scrambled peptide administered rabbits. The difference of I/M
CS1 peptide group disappeared with CS1 peptide administration. (B) Represen-
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